The first doses of the newly approved Alzheimer’s drug “Leqembi” were administered in Louisville. More than 100 people have signed up since then. See why.
Biogen reprioritize resources allocated to ADUHELM® to advance LEQEMBI®.
At long last, we finally have a disease-modifying drug for Alzheimer’s. The FDA recently approved a new drug that promises to slow the progression of the disease. Only five Alzheimer’s treatments have been approved by the FDA up until a decade ago, and this is only the second to address the progression of the disease.
FDA-approved ADLARITY is the once-weekly donepezil patch. See how it compares to donepezil / Aricept / Ebixa tablets for Alzheimer’s.
Now, a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA),. The field of new drugs is beginning to show progress in the fight to slow the disease.
First drug to modestly slow Alzheimer’s cognitive decline, based on 1,800 patients.
The FDA Advisory Committee’s endorsement of Leqembi paves way for traditional approval, ushers in a new era for Alzheimer’s
Researchers find that people with dementia who received the drug suvorexant showed a drop in tau and amyloid beta. The drug is already available for sleep problems in Alzheimer’s. Learn more.
NAMENDA® / EBIXA® (generic MEMANTINE) is FDA-approved for Alzheimer’s. Learn about new research on how it may help in preventing or slowing dementia.
Research shows that lecanemab is the first drug ever to slow cognitive decline in Alzheimer’s. Learn more.
At this time of year, it’s healthy to get some air and sunshine. It’s especially good for those with dementia.
60% of people with Alzheimer’s wander. Robert surprised everyone when he wandered off at sunset. Police dogs began a 16-hour tense, fruitless search. WMTW-TV arrived to broadcast the news. See Robert wander right into the newscast.
TEDx HEALTH VIDEO:
Alzheimer’s & brain insulin are so strongly connected, it’s earned Alzheimer’s the nickname, “Type-3 Diabetes.” Watch this eye-opening, entertaining video to understand the connection. Find out what you can do.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.
